In another study of 704 men with metastatic prostate cancer, only one BARD1 mutation was detected (0.14%) compared to 0.09% in 54,802 reference controls from Genome Aggregation database (p = 0.46) [38]. Here, BARD1 is linked to metastatic prostate carcinoma.